Matrix-Adhesion Isolation of High-Purity Vascular Endothelial Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for isolating and culturing vascular endothelial cells from human pluripotent stem cells face challenges in maintaining cell purity and viability, leading to reduced therapeutic efficacy due to impurities, aging, and unsuitable culture conditions.
Innovation Solution
A method involving matrix adhesion-based separation and a specialized culture medium using FGF, EGF, VEGF-A, and ascorbic acid in DMEM/F-12 medium to isolate and maintain high-purity vascular endothelial cells, with a culture process that includes filtering, matrix adhesion, and controlled culture times to preserve cell characteristics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional culture methods are used to isolate vascular endothelial cells, then cell quantity can be increased, but cell purity decreases due to contamination with other cell types
Solution Approach 1:
The patent divides the culture process into distinct stages: initial culture on matrix-coated plates for selective adhesion, followed by passage culture in suspension. This segmentation allows separation of endothelial cells from other cell types during the adhesion phase, achieving high purity (98% or more) while maintaining sufficient cell quantity for therapeutic use
Solution Approach 2:
The patent uses a matrix coating (such as collagen, fibronectin, or laminin) as an intermediary substance that selectively promotes adhesion of vascular endothelial cells while preventing adhesion of other cell types. This intermediary enables pure isolation of endothelial cells without requiring complex purification steps
2Quantity of substance
If cells are cultured for extended periods to increase quantity, then cell yield improves, but cell characteristics deteriorate due to aging
Solution Approach 1:
The patent implements periodic passage culture where cells are harvested and re-cultured at regular intervals. This periodic action prevents cells from entering senescence by maintaining them in a continuous growth cycle, thereby preserving cell characteristics while achieving the required cell yield for therapy
Solution Approach 2:
The patent uses growth factors (such as FGF-2, VEGF-A, EGF) in the culture medium that stimulate cells to maintain their own proliferation and characteristics. This self-service approach allows cells to sustain their functional properties while being expanded in quantity
3Ease of manufacture
If standard culture media are used to simplify the process, then ease of manufacture improves, but cell viability decreases due to unsuitable conditions
Solution Approach 1:
The patent optimizes specific parameters of the culture medium including the addition of growth factors (FGF-2, VEGF-A, EGF), ascorbic acid, and specific serum concentrations. These parameter changes create optimal conditions for endothelial cell survival and function while maintaining a relatively simple culture protocol that can be implemented in standard laboratories
4Manufacturing precision
If matrix adhesion time is extended to improve separation purity, then cell purity increases, but culture time increases reducing productivity
Solution Approach 1:
The patent pre-coats culture plates with matrix substances before cell seeding. This preliminary action prepares the surface to selectively adhere endothelial cells, allowing the separation process to proceed efficiently without requiring extended culture times. The pre-prepared matrix coating enables high purity separation (98% or more) while maintaining a compact culture timeline suitable for clinical production
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high-purity vascular endothelial cells with enhanced angiogenic ability, suitable for clinical applications, and maintains cell characteristics through multiple passages, providing a stable cell therapeutic agent for cardiovascular disease treatment.
Implementation Method 1
matrix adhesion varies depending on the characteristics of differentiated endothelial cells. When cells were separated according to a specific adhesion time due to matrix adhesion, homogeneous vascular endothelial cells could be isolated with high purity.
Data Source
AI summary
The present specification provides: a method of isolation of a pure culture of vascular endothelial cells, the method capable of isolating homogeneous endothelial cells adhered to a matrix for a specific time in a cell line of an endothelial cell lineage differentiated from human pluripotent stem cells; a medium for maintaining characteristics of vascular endothelial cells, comprising high-purity vascular endothelial cells isolated through the method, 4 ng/ml to 6 ng/ml of FGF2, 5 ng/ml to 10 ng/ml of EGF, 10 ng/ml to 30 ng/ml of VEGF-A, 20 ng/ml to 50 ng/ml of ascorbic acid, and DMEM/F-12 as active ingredients; and a culture method comprising same.